Boston Scientific Corporation (BSX) financial statements (2022 and earlier)

Company profile

Business Address 300 BOSTON SCIENTIFIC WAY
MARLBOROUGH, MA 01752-1234
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,9251,734217146188196319
Cash and cash equivalents1,9251,734217146188196319
Restricted cash and investments   655   
Receivables1,7781,5311,8281,6081,5481,4721,275
Inventory, net of allowances, customer advances and progress billings1,6101,3511,5791,1661,0789551,016
Inventory1,6101,3511,5791,1661,0789551,016
Prepaid expense205194     
Disposal group, including discontinued operation 1,133     
Other current assets     240 
Other undisclosed current assets7997511,0754281,008376861
Total current assets:6,3176,6944,6994,0033,8223,2393,471
Noncurrent Assets
Property, plant and equipment2,2522,0842,0791,7821,6971,6301,490
Long-term investments and receivables  264    
Long-term investments  264    
Intangible assets, net (including goodwill)18,10915,86818,06214,28312,83512,56112,667
Goodwill11,9889,95110,1767,9116,9986,6786,473
Intangible assets, net (excluding goodwill)6,1215,9177,8866,3725,8375,8836,194
Restricted cash and investments  86    
Deferred income tax assets4,1424,210 
Other noncurrent assets1,4101,9211,529932688666505
Other undisclosed noncurrent assets(1) 3,846(1)   
Total noncurrent assets:25,91224,08325,86616,99615,22014,85714,662
TOTAL ASSETS:32,22930,77730,56520,99919,04218,09618,133
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,2302,7102,6512,5952,9862,7592,179
Accounts payable794513542349530447209
Accrued liabilities2,4362,1972,1092,2462,4562,3121,970
Debt261131,4162,2531,801643
Other liabilities783958800412867764248
Other undisclosed current liabilities  (1)    
Total current liabilities:4,2743,6814,8665,2605,6543,5872,430
Noncurrent Liabilities
Long-term debt and lease obligation, including:8,8049,1308,5924,8033,8155,4205,674
Other undisclosed long-term debt and lease obligation8,8049,1308,5924,8033,8155,4205,674
Liabilities, other than long-term debt2,5302,6393,2302,2102,5612,3563,709
Deferred tax liabilities, net59532819118735
Deferred income tax liabilities310330 
Other liabilities2,2202,3092,6351,8822,3702,3382,974
Other undisclosed noncurrent liabilities(1)1     
Total noncurrent liabilities:11,33311,77011,8227,0136,3767,7769,383
Total liabilities:15,60715,45116,68812,27312,03011,36311,813
Stockholders' equity
Stockholders' equity attributable to parent16,36015,12013,8778,7257,0116,7336,320
Common stock17171616161616
Treasury stock, value(2,251)(2,251)(1,717)(1,717)(1,717)(1,717)(1,717)
Additional paid in capital19,98619,73217,56117,34617,16117,01416,860
Accumulated other comprehensive income (loss)  27033(59)188
Accumulated deficit(1,392)(2,378)(2,253)(6,953)(8,390)(8,581)(8,927)
Other undisclosed stockholders' equity262206 11  
Total stockholders' equity:16,62215,32613,8778,7267,0126,7336,320
TOTAL LIABILITIES AND EQUITY:32,22930,77730,56520,99919,04218,09618,133

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues11,8889,91310,7359,8239,0489,0768,068
Revenue, net9,0488,3867,477
Cost of revenue
(Cost of Goods and Services Sold)
(3,711)(3,465)(3,116)(2,813)(2,593)(2,424)(2,173)
Other undisclosed gross profit  11 (690)(591)
Gross profit:8,1776,4487,6207,0116,4555,9625,304
Operating expenses(6,978)(6,528)(6,102)(5,504)(5,170)(5,515)(5,631)
Other undisclosed operating loss   (1)   
Operating income (loss):1,199(80)1,5181,5061,285447(327)
Nonoperating income (expense)(123)1(831)(85)(353)(270)(69)
Investment income, nonoperating328398(22)155(92)(21)(9)
Foreign currency transaction loss, before tax     (13)(21)
Other nonoperating income (expense)218362(358)156(124)(37)(39)
Interest and debt expense(341)(361)(473)(241)(229)(233)(284)
Income (loss) from continuing operations before equity method investments, income taxes:735(440)2141,180703(56)(680)
Other undisclosed income from continuing operations before income taxes34136147324223023330
Income (loss) from continuing operations before income taxes:1,076(79)6871,422933177(650)
Income tax expense (benefit)(36)(2)4,013249(828)170411
Income (loss) before gain (loss) on sale of properties:1,040(81)4,7001,671105347(239)
Other undisclosed net income (loss)1(1)  (1)  
Net income (loss) attributable to parent:1,041(82)4,7001,671104347(239)
Other undisclosed net loss available to common stockholders, basic(56)(33)     
Net income (loss) available to common stockholders, diluted:985(115)4,7001,671104347(239)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):1,041(82)4,7001,671104347(239)
Other comprehensive income (loss)56(63)23791(59)(87)(56)
Other undisclosed comprehensive loss(1)  (1)   
Comprehensive income (loss), net of tax, attributable to parent:1,096(145)4,9371,76145260(295)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: